Calendar GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Market Closed -
NSE India S.E.
12:05:08 18/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,877.40 INR | +6.46% |
|
+10.59% | +16.32% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Chart calendar GlaxoSmithKline Pharmaceuticals Limited
Upcoming events on GlaxoSmithKline Pharmaceuticals Limited
| 13/09/2026 | Extraordinary General Meeting |
Past events on GlaxoSmithKline Pharmaceuticals Limited
| 03/08/2026 | Présentation aux Actionnaires / Analystes | |
| 03/08/2026 | Board of Directors Meeting | |
| 03/08/2026 | Earnings release - Q1 2027 | |
| 30/06/2026 | Présentation aux Actionnaires / Analystes | 06:30 |
| 30/06/2026 | Annual General Meeting | 06:30 |
| 13/05/2026 | Earnings release - Q4 2026 | |
| 13/05/2026 | Board of Directors Meeting | |
| 13/05/2026 | Présentation aux Actionnaires / Analystes | |
| 08/04/2026 | Extraordinary General Meeting | |
| 02/03/2026 | Board of Directors Meeting | 05:30 |
| 09/02/2026 | Earnings release - Q3 2026 | |
| 09/02/2026 | Présentation aux Actionnaires / Analystes | |
| 09/02/2026 | Board of Directors Meeting | |
| 06/11/2025 | Board of Directors Meeting | 08:30 |
| 06/11/2025 | Earnings release - Q2 2026 | |
| 06/11/2025 | Présentation aux Actionnaires / Analystes |
Past dividends on GlaxoSmithKline Pharmaceuticals Limited
| 29/05/2026 | Ex-dividend date - 57 INR | 05:00 |
Annual results
| Fiscal Period | March | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 34 537 33 649 2.64% | 37 492 37 586 -0.25% | 38 217 38 852 -1.63% | 42 528 | 47 167 |
|
EBITDA Million INR | Released Forecast Spread | 9 087 8 671 4.8% | 11 774 11 381 3.45% | 13 092 13 371 -2.08% | 14 794 | 17 020 |
|
EBIT Million INR | Released Forecast Spread | 8 390 8 450 -0.71% | 11 106 11 177 -0.64% | 12 428 12 697 -2.12% | 14 621 | 17 016 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 8 162 9 325 -12.47% | 12 599 12 161 3.6% | 14 060 14 072 -0.09% | 15 648 | 17 879 |
|
Net income Million INR | Released Forecast Spread | 5 900 6 063 -2.7% | 9 276 8 911 4.09% | 10 360 10 443 -0.8% | 11 611 | 13 364 |
|
EPS INR | Released Forecast Spread | 34,8 40,2 -13.36% | 54,8 52,9 3.45% | 61,2 61,1 0.14% | 68,5 | 78,9 |
| Announcement Date | 17/05/24 | 13/05/25 | 13/05/26 | - |
Quarterly results
| Fiscal Period | March | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 10 108 10 330 -2.15% | 9 494 8 788 8.04% | 9 744 9 925 -1.83% | 8 052 8 812 -8.62% | 9 799 10 641 -7.91% | 10 413 10 270 1.39% | 9 953 10 715 -7.11% | 9 384 9 112 3% | 11 275 | 11 749 | 11 273 |
|
EBITDA Million INR | Released Forecast Spread | 3 264 3 243 0.64% | 2 919 2 511 16.28% | 3 332 2 925 13.91% | 2 512 2 633 -4.61% | 3 384 3 451 -1.94% | 3 713 3 477 6.81% | 3 509 3 758 -6.61% | 2 955 3 005 -1.65% | 4 003 | 4 277 | 3 878 |
|
EBIT Million INR | Released Forecast Spread | 3 095 2 820 9.77% | 2 731 2 338 16.82% | 3 185 2 615 21.79% | 2 357 2 501 -5.77% | 3 209 3 159 1.6% | 3 378 3 735 -9.57% | 2 797 2 703 3.46% | 3 804 | 4 070 | 3 679 | |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 3 438 3 126 9.98% | 3 081 2 635 16.93% | 3 586 2 958 21.22% | 2 790 2 796 -0.22% | 3 540 3 456 2.43% | 3 999 3 745 6.79% | 3 731 4 294 -13.11% | 3 225 3 081 4.66% | 4 181 | 4 447 | 4 056 |
|
Net income Million INR | Released Forecast Spread | 2 525 2 496 1.16% | 2 299 1 939 18.56% | 2 629 2 255 16.57% | 2 050 2 112 -2.93% | 2 575 2 669 -3.53% | 2 956 2 690 9.9% | 2 779 3 156 -11.96% | 2 372 2 297 3.26% | 3 115 | 3 313 | 3 022 |
|
EPS INR | Released Forecast Spread | 14,0 13,9 0.72% | ||||||||||
| Announcement Date | 29/10/24 | 14/02/25 | 13/05/25 | 01/08/25 | 06/11/25 | 09/02/26 | 13/05/26 | 03/08/26 | - | - | - |
| 20/08/2026 |  | Earnings release - Q2 2026 | |
| 20/08/2026 | | Board of Directors Meeting | |
| 20/08/2026 | | Extraordinary General Meeting | 07:00 |
| 20/08/2026 | | Earnings release - Q2 2026 | |
| 20/08/2026 | | Earnings presentation | 12:30 |
| 20/08/2026 | | Earnings release - Q2 2026 | |
| 20/08/2026 | | Ex-dividend date - 1.5 INR | 05:00 |
| 20/08/2026 | | Information meeting | 04:30 |
| 20/08/2026 | | Ex-dividend date - 0.9 INR | 05:00 |
| 20/08/2026 | | Earnings release - Q2 2026 |
Past sector events for GlaxoSmithKline Pharmaceuticals Limited
| Today | | Earnings release - Q2 2026 | |
| Today | | Board of Directors Meeting | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Board of Directors Meeting | |
| Today | | Information meeting | 04:30 |
| Today | | Earnings presentation | 03:00 |
| 18/08/2026 | | Earnings release - Q2 2026 | |
| 18/08/2026 | | Information meeting | |
| 18/08/2026 | | Earnings release - Q2 2026 | |
| 18/08/2026 | | Extraordinary General Meeting | 07:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
- GLAXO Stock
- Calendar GlaxoSmithKline Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
